Chain Drug Review - KV Receives FDA Approval For Marketing Generic Imdur
April 10, 2000 -- KV Pharmaceutical Co. has received Food and Drug Administration approval of its Abbreviated New Drug Application for a generic alternative to the...
Business Wire - Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
August 23, 2007 -- Company taps former Kos Pharmaceuticals executives to head key growth functions WALTHAM, Mass. -- Oscient Pharmaceuticals Corporation (Nasdaq:...
Business Wire - Kremers Urban Introduces First-to-Market Generic Equivalent to Imdur
November 3, 1998 -- MEQUON, Wisc.--(BW HealthWire)--Nov. 3, 1998--Kremers Urban announced FDA approval of a generic equivalent of Imdur(R) on Friday October 30 and began...
Australian Nursing Journal - Crushed medications: an emerging guideline.(clinical update)
July 1, 2005 -- Introduction Many patients are unable to swallow tablets in their whole presentation and therefore crush them, or have them crushed by carers,...
Business Wire - Key Pharmaceuticals announces IMDUR added to Medi-Cal formulary for treatment of angina
April 1, 1996 -- KENILWORTH, N.J.--(BUSINESS WIRE)--April 1, 1996--Key Pharmaceuticals announced today that IMDUR(R) (isosorbide mononitrate) Extended Release...
Business Wire - IVAX Receives Generic Drug Approval for Isosorbide Mononitrate Extended-Release Tablets
August 9, 2001 -- Business Editors/Health & Medical Writers MIAMI--(BW HealthWire)--Aug. 9, 2001 IVAX Corporation (AMEX:IVX)(LSE:IVX.L) received approval for its...
Business Wire - IVAX Distributes Letter To Shareholders
August 14, 2001 -- Business Editors & Health/Medical Writers MIAMI--(BW HealthWire)--Aug. 14, 2001 IVAX Corporation (AMEX:IVX)(LSE:IVX.L) will distribute a letter...
Encyclopedia of Medicine - Heart attack
April 6, 2001 -- DefinitionA heart attack is the death of, or damage to, part of the heart muscle because the supply of blood to the heart muscle is...
Business Wire - IVAX Announces Generic Drug Approval for Isosorbide Mononitrate Extended-Release Tablets
June 23, 2000 -- Business Editors MIAMI--(BUSINESS WIRE)--June 23, 2000 IVAX Corporation (AMEX:IVX) today announced that the United States Food and Drug...
Business Wire - Faulding Receives US FDA Approval For Extended-Release Isosorbide Mononitrate Tablets
January 5, 1999 -- UNDERDALE, South Australia--(BUSINESS WIRE)--Jan. 5, 1998-- International pharmaceutical and healthcare company, F H Faulding & Co Limited...
